You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

CLINICAL TRIALS PROFILE FOR BEMPEDOIC ACID

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Bempedoic Acid

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02666664 ↗	Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)	Completed	Esperion Therapeutics	Phase 3	2016-01-21	The purpose of this study is to see if ETC-1002 (bempedoic acid) is safe and well-tolerated versus placebo in patients with high cardiovascular risk and elevated LDL cholesterol that is not adequately controlled by their current therapy.
NCT02666664 ↗	Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)	Completed	Esperion Therapeutics, Inc.	Phase 3	2016-01-21	The purpose of this study is to see if ETC-1002 (bempedoic acid) is safe and well-tolerated versus placebo in patients with high cardiovascular risk and elevated LDL cholesterol that is not adequately controlled by their current therapy.
NCT02988115 ↗	Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant	Completed	Esperion Therapeutics	Phase 3	2016-11-16	The purpose of this study is to determine if bempedoic acid (ETC-1002) is effective and safe versus placebo in patients with elevated LDL cholesterol and who are statin-intolerant.
NCT02988115 ↗	Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant	Completed	Esperion Therapeutics, Inc.	Phase 3	2016-11-16	The purpose of this study is to determine if bempedoic acid (ETC-1002) is effective and safe versus placebo in patients with elevated LDL cholesterol and who are statin-intolerant.
NCT02991118 ↗	Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk	Completed	Esperion Therapeutics	Phase 3	2016-11-18	The purpose of this study is to see if bemedoic acid (ETC-1002) is effective versus placebo in patients with high cardiovascular risk and elevated LDL cholesterol not adequately controlled by their current therapy.
NCT02991118 ↗	Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk	Completed	Esperion Therapeutics, Inc.	Phase 3	2016-11-18	The purpose of this study is to see if bemedoic acid (ETC-1002) is effective versus placebo in patients with high cardiovascular risk and elevated LDL cholesterol not adequately controlled by their current therapy.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Bempedoic Acid

Condition Name

Chart
Table

Condition Name for Bempedoic Acid
Intervention	Trials
Hypercholesterolemia	9
Statin Adverse Reaction	3
Cardiovascular Diseases	3
Atherosclerotic Cardiovascular Disease	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Bempedoic Acid
Intervention	Trials
Hypercholesterolemia	9
Cardiovascular Diseases	7
Atherosclerosis	6
Hyperlipidemias	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Bempedoic Acid

Trials by Country

Map
Table

Trials by Country for Bempedoic Acid
Location	Trials
United States	111
United Kingdom	23
Brazil	18
India	14
Germany	12
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Bempedoic Acid
Location	Trials
Florida	6
California	6
Virginia	5
Texas	5
North Carolina	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Bempedoic Acid

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Bempedoic Acid
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	8
Phase 2	5
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Bempedoic Acid
Clinical Trial Phase	Trials
Completed	9
Recruiting	3
Not yet recruiting	2
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Bempedoic Acid

Sponsor Name

Chart
Table

Sponsor Name for Bempedoic Acid
Sponsor	Trials
Esperion Therapeutics, Inc.	12
Esperion Therapeutics	10
Otsuka Pharmaceutical Co., Ltd.	1
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Bempedoic Acid
Sponsor	Trials
Industry	23
Other	8
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.